MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
21 Giugno 2024 - 1:00PM
Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or
“MindMed”), a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders, announced
today that members of the Company’s management team will present at
the H.C. Wainwright 5th Annual Neuro Perspectives Virtual
Conference being held on June 27, 2024.
A webcast of the fireside chat will be accessible on MindMed’s
Investor Relations website starting on June 27, 2024 at 7:00 AM ET
and will remain available for replay on the website for up to 90
days following the event.
About MindMed
MindMed is a clinical stage biopharmaceutical company developing
novel product candidates to treat brain health disorders. Our
mission is to be the global leader in the development and delivery
of treatments that unlock new opportunities to improve patient
outcomes. We are developing a pipeline of innovative product
candidates, with and without acute perceptual effects, targeting
neurotransmitter pathways that play key roles in brain health
disorders. MindMed trades on NASDAQ under the symbol MNMD.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240621380316/en/
For Media: media@mindmed.co For Investors:
ir@mindmed.co
Grafico Azioni Mind Medicine MindMed (NASDAQ:MNMD)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Mind Medicine MindMed (NASDAQ:MNMD)
Storico
Da Giu 2023 a Giu 2024
